Equasens: 2023 revenue: €219.7m, +2.6%
06 févr. 2024 12h00 HE
|
EQUASENS
Villers-lès-Nancy, 6 February 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 revenue: €219.7m, +2.6% Equasens Group reported growth in annual revenue, despite an unfavourable comparison base from the...
Castellum Announces Closing of $2.7 Million Registered Direct Offering
29 janv. 2024 16h30 HE
|
Castellum, Inc.
Castellum, Inc. (the “Company”) (NYSE-American: CTM) closes on registered direct offering, consisting of the sale of 8,437,501 shares.
EGIDE : Renforcement de la structure actionnariale et Remboursement de l’emprunt obligataire
20 déc. 2023 02h00 HE
|
EGIDE
Communiqué de presse Bollène, 20 décembre 2023– 08h00 (CET) Renforcement de la structure actionnariale & Remboursement de l’emprunt obligataire Egide (Euronext Growth Paris™- ISIN : FR0000072373...
BRBS Shareholders Should Contact Robbins LLP the Blue Ridge Bankshares, Inc. Lawsuit
19 déc. 2023 12h37 HE
|
Robbins LLP
Blue Ridge Bankshares, Inc. (BRBS) Has to Restate its Financial Statements due to Inadequate Internal Controls over Financial Reporting
Barclays PLC STOCK ALERT: Robbins LLP Reminds Investors of the Pending Lead Plaintiff Deadline in the Class Action Against BCS
15 déc. 2023 19h11 HE
|
Robbins LLP
Barclays (BCS) Misled Investors About the Relationship Between its CEO and Jeffrey Epstein
Egide: Successful capital increase with gross proceeds of 1.9 million euros
13 déc. 2023 03h06 HE
|
EGIDE
Press release Bollène, December 12, 2023 – 8:00am (CET) A successful capital increase with gross proceeds of 1.9 million euros Subscription applications received for 4,462,513 new shares, i.e. a...
EGIDE : Succès de l'augmentation de capital d'un montant brut de 1,9 million d'euros
12 déc. 2023 02h00 HE
|
EGIDE
Communiqué de presse Bollène, le 12 décembre 2023– 8h00 (CET) Succès de l’augmentation de capitald’un montant brut de 1,9 million d’euros Demandes de souscription portant sur 4 462 513 actions...
Castellum, Inc. Announces Execution of Debt Term Sheet
27 nov. 2023 06h45 HE
|
Castellum, Inc.
Castellum, Inc. Announces Execution of Debt Term Sheet
EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
23 nov. 2023 12h00 HE
|
EQUASENS
Villers-lès-Nancy, le 23 novembre 2023 – 18:00 (CET) COMMUNIQUE DE PRESSE Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany EQUASENS, en association avec ARZ HAAN, un des leaders sur...
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
23 nov. 2023 12h00 HE
|
EQUASENS
Villers-lès-Nancy, 23 November 2023 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of the German company ADVand creation of PHARMAGEST Germany EQUASENS, in partnership with ARZ HAAN, a German market...